Clinical trial
Rosuvastatin and Ischemia Reperfusion
NCT00315510 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00315510 |
|---|---|
| Title | Rosuvastatin and Ischemia Reperfusion |
| Official title | Does Rosuvastatin Reduce Ischemia/Reperfusion Injury in Humans In-Vivo? A Randomized Double Blind Placebo Controlled Trial |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ischemia |
| Intervention type | Drug |
| Interventions | Rosuvastatin |
| Enrollment | 20 |
| Start date | Apr 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | Apr 18, 2006 |
| Last update posted | Sep 23, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: